Analysts revised Aspen Pharmacare (JSE:APN) average one-year price target to R146.20, a 21.81% increase from the prior R120.02 target dated 21-Feb-2026. The new target is an average of multiple analyst estimates and signals materially higher expected upside for the stock, likely influencing near-term share moves at the single-stock level.
Analysts revised Aspen Pharmacare (JSE:APN) average one-year price target to R146.20, a 21.81% increase from the prior R120.02 target dated 21-Feb-2026. The new target is an average of multiple analyst estimates and signals materially higher expected upside for the stock, likely influencing near-term share moves at the single-stock level.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.40
